Litcius/Paper detail

Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor

Zhengguang Zhang, Yuanyuan Guo, Meijuan Chen, Feiyan Chen, Bing Liu, Cunsi Shen

2021Inflammopharmacology36 citationsDOI

Topics & Concepts

ErlotinibEpidermal growth factor receptorEGFR inhibitorsProtein kinase BCancer researchPI3K/AKT/mTOR pathwayCell growthApoptosisPharmacologySignal transductionMedicineChemistryReceptorInternal medicineBiochemistryPancreatic and Hepatic Oncology ResearchLung Cancer Treatments and MutationsColorectal Cancer Treatments and Studies
Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor | Litcius